# First person – Lucie Perillat

PMC · DOI: 10.1242/dmm.052050 · 2025-09-29

## TL;DR

Lucie Perillat discusses her research on a mouse model for Becker muscular dystrophy and her work on ethical frameworks for childhood disorder therapies.

## Contribution

The paper introduces a new mouse model for Becker muscular dystrophy with a specific Dmd exon deletion.

## Key findings

- A mouse model with a deletion of Dmd exons 52 to 55 was successfully generated.
- The model is being characterized to study Becker muscular dystrophy.

## Abstract

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Lucie Perillat is co-first author on ‘
Generation and characterization of a mouse model of Becker muscular dystrophy with a deletion of Dmd exons 52 to 55’, published in DMM. Lucie is a PhD student in the lab of Dr Ronald Cohn and Dr Evgueni Ivakine at The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada. Her research interests lie in the development of individualized therapies for rare childhood disorders, and the creation of a robust ethical framework to expedite their clinical translation while ensuring the protection of all parties involved – patients and families, scientists, and institutions.

## Linked entities

- **Genes:** DMD (dystrophin) [NCBI Gene 1756]
- **Diseases:** Becker muscular dystrophy (MONDO:0010311)
- **Species:** Mus musculus (taxon 10090)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12519543/full.md

---
Source: https://tomesphere.com/paper/PMC12519543